Table of Contents Author Guidelines Submit a Manuscript
Journal of Chemistry
Volume 2017 (2017), Article ID 5752090, 10 pages
https://doi.org/10.1155/2017/5752090
Research Article

Preparation and Optimization of 10-Hydroxycamptothecin Nanocolloidal Particles Using Antisolvent Method Combined with High Pressure Homogenization

1Key Laboratory of Forest Plant Ecology, Northeast Forestry University, Ministry of Education, Harbin, Heilongjiang 150040, China
2School of Food Science and Technology, National Engineering Research Center of Seafood, Dalian Polytechnic University, Dalian, Liaoning 116034, China

Correspondence should be addressed to Xiuhua Zhao and Yuangang Zu

Received 27 February 2017; Accepted 20 April 2017; Published 24 May 2017

Academic Editor: José L. Arias Mediano

Copyright © 2017 Bolin Lian et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Y.-F. Li and R. Zhang, “Reversed-phase high-performance liquid chromatography method for the simultaneous quantitation of the lactone and carboxylate forms of the novel natural product anticancer agent 10-hydroxycamptothecin in biological fluids and tissues,” Journal of Chromatography B: Biomedical Applications, vol. 686, no. 2, pp. 257–265, 1996. View at Publisher · View at Google Scholar · View at Scopus
  2. T. G. Burke and Z. Mi, “Preferential binding of the carboxylate form of camptothecin by human serum albumin,” Analytical Biochemistry, vol. 212, no. 1, pp. 285–287, 1993. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Hatefi and B. Amsden, “Camptothecin delivery methods,” Pharmaceutical Research, vol. 19, no. 10, pp. 1389–1399, 2002. View at Publisher · View at Google Scholar · View at Scopus
  4. L. P. Rivory and J. Robert, “Reversed-phase high-performance liquid chromatographic method for the simultaneous quantitation of the carboxylate and lactone forms of the camptothecin derivative irinotecan, CPT-11, and its metabolite SN-38 in plasma,” Journal of Chromatography B: Biomedical Sciences and Applications, vol. 661, no. 1, pp. 133–141, 1994. View at Publisher · View at Google Scholar · View at Scopus
  5. T. Tadros, P. Izquierdo, J. Esquena, and C. Solans, “Formation and stability of nano-emulsions,” Advances in Colloid and Interface Science, vol. 108-109, pp. 303–318, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. L. Yang, F. Cui, D. Cun, A. Tao, K. Shi, and W. Lin, “Preparation, characterization and biodistribution of the lactone form of 10-hydroxycamptothecin (HCPT)-loaded bovine serum albumin (BSA) nanoparticles,” International Journal of Pharmaceutics, vol. 340, no. 1-2, pp. 163–172, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. R. Zhang, Y. Li, Q. Cai, T. Liu, H. Sun, and B. Chambless, “Preclinical pharmacology of the natural product anticancer agent 10-hydroxycamptothecin, an inhibitor of topoisomerase I,” Cancer Chemotherapy and Pharmacology, vol. 41, no. 4, pp. 257–267, 1998. View at Publisher · View at Google Scholar · View at Scopus
  8. D. Chena, S. Chena, Q. Wanga, P. Guoa, Y. Caoa, and D. Lib, “Intracellular delivery of 10-hydroxycamptothecin with novel solid lipid nanoparticles (SLN) against multidrug resistance,” Abstracts/Journal of Controlled Release, vol. 172, pp. e14–e97, 2013. View at Publisher · View at Google Scholar
  9. M. Hong, S. Zhu, Y. Jiang et al., “Novel anti-tumor strategy: PEG-hydroxycamptothecin conjugate loaded transferrin-PEG-nanoparticles,” Journal of Controlled Release, vol. 141, no. 1, pp. 22–29, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. J.-B. Qu, H.-H. Shao, G.-L. Jing, and F. Huang, “PEG-chitosan-coated iron oxide nanoparticles with high saturated magnetization as carriers of 10-hydroxycamptothecin: preparation, characterization and cytotoxicity studies,” Colloids and Surfaces B: Biointerfaces, vol. 102, pp. 37–44, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Wang, R. Wang, and L. B. Li, “Preparation and properties of hydroxycamptothecin-loaded nanoparticles made of amphiphilic copolymer and normal polymer,” Journal of Colloid and Interface Science, vol. 336, no. 2, pp. 808–813, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. Z. Yang, W. Gong, Z. Wang et al., “A novel drug-polyethylene glycol liquid compound method to prepare 10-hydroxycamptothecin loaded human serum albumin nanoparticle,” International Journal of Pharmaceutics, vol. 490, no. 1-2, pp. 412–428, 2015. View at Publisher · View at Google Scholar · View at Scopus
  13. L. Zhang, M. Yang, Q. Wang et al., “10-Hydroxycamptothecin loaded nanoparticles: preparation and antitumor activity in mice,” Journal of Controlled Release, vol. 119, no. 2, pp. 153–162, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. X. Zhao, R. Jiang, Y. Zu et al., “Process optimization studies of 10-Hydroxycamptothecin (HCPT)-loaded folate-conjugated chitosan nanoparticles by SAS-ionic crosslink combination using response surface methodology (RSM),” Applied Surface Science, vol. 258, no. 6, pp. 2000–2005, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. B. van Eerdenbrugh, L. Froyen, J. A. Martens et al., “Characterization of physico-chemical properties and pharmaceutical performance of sucrose co-freeze-dried solid nanoparticulate powders of the anti-HIV agent loviride prepared by media milling,” International Journal of Pharmaceutics, vol. 338, no. 1-2, pp. 198–206, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. T. L. Rogers, I. B. Gillespie, J. E. Hitt et al., “Development and characterization of a scalable controlled precipitation process to enhance the dissolution of poorly water-soluble drugs,” Pharmaceutical Research, vol. 21, no. 11, pp. 2048–2057, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. P. Kocbek, S. Baumgartner, and J. Kristl, “Preparation and evaluation of nanosuspensions for enhancing the dissolution of poorly soluble drugs,” International Journal of Pharmaceutics, vol. 312, no. 1-2, pp. 179–186, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. K. P. Krause and R. H. Müller, “Production and characterisation of highly concentrated nanosuspensions by high pressure homogenisation,” International Journal of Pharmaceutics, vol. 214, no. 1-2, pp. 21–24, 2001. View at Publisher · View at Google Scholar · View at Scopus
  19. E. Reverchon, G. Della Porta, and P. Pallado, “Supercritical antisolvent precipitation of salbutamol microparticles,” Powder Technology, vol. 114, no. 1–3, pp. 17–22, 2001. View at Publisher · View at Google Scholar · View at Scopus
  20. X. Zhao, Y. Zu, R. Jiang et al., “Preparation and physicochemical properties of 10-hydroxycamptothecin (HCPT) nanoparticles by supercritical antisolvent (SAS) process,” International Journal of Molecular Sciences, vol. 12, no. 4, pp. 2678–2691, 2011. View at Publisher · View at Google Scholar · View at Scopus